Anwar Ibrahim, Malaysia's Prime Minister, has revealed a significant financial achievement in the healthcare sector. The government has reportedly saved approximately RM1 billion by transitioning from expensive originator medicines to generic drugs. This shift in procurement strategy is a strategic move towards cost-effectiveness and accessibility in healthcare.
Anwar emphasized the potential for substantial savings by adopting generic medicines, which are often significantly cheaper than their originator counterparts. He highlighted the example of a medication where a pill from the US costs RM100, but the same medication can be sourced from countries like India, Turkey, Brazil, or China for as little as RM10, provided it meets the necessary medical standards. This approach challenges the traditional pride in purchasing expensive medications from the US and Europe.
The Prime Minister also addressed the issue of prolonged timelines for public health infrastructure projects, citing the recent completion of the Seberang Jaya hospital building, which took longer than expected. He called for faster land approvals and more efficient project management to ensure timely completion of healthcare facilities.
Health Minister Dzulkefly Ahmad supported the generic drug policy, assuring the public that generic medicines are as safe and effective as originator drugs. He mentioned that this policy has led to increased prescribing of generic medicines in public health facilities, resulting in significant savings of at least RM900 million in the last two years. The minister also mentioned ongoing efforts to review and expedite delayed health projects across the country.
